Opportunity Information: Apply for PA 18 852
The National Institutes of Health (NIH), through the National Cancer Institute (NCI), announced a discretionary grant opportunity titled "Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed)" under funding opportunity number PA 18 852 (CFDA 93.396). This program is designed as an administrative supplement mechanism, meaning it provides additional funds to expand or enhance work that is already supported under an active NCI parent award, rather than funding an entirely new standalone project. The focus is firmly on basic cancer biology, with an emphasis on tackling challenging research questions by encouraging collaborations that cut across disciplines and bring complementary expertise together.
A central requirement of the opportunity is that the proposed supplement must be built around a genuine collaboration involving at least two researchers, and one of those collaborators must be the principal investigator (PI) of the existing parent NCI grant. The intent is that the supplement activity will leverage the infrastructure, aims, and momentum of the currently funded project while extending it in a meaningful way through partnership. In practical terms, NCI is trying to motivate teams to combine skill sets, approaches, or technologies that may not be present within a single laboratory or research group, thereby accelerating progress in basic cancer research through multidisciplinary teamwork. As indicated by the title and instructions, clinical trials are not allowed under this supplement, reinforcing that the supported work should remain within the boundaries of basic, preclinical, or fundamental cancer biology research rather than interventional human studies.
Eligibility is broad and includes many types of domestic applicants commonly allowed under NIH grants, such as state, county, and local governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; special district governments; and public housing authorities or Indian housing authorities. The announcement also allows nonprofit organizations both with and without 501(c)(3) status, for-profit organizations (other than small businesses), and small businesses. In addition, the FOA explicitly highlights a range of institutions and organizations that are also eligible or welcomed as applicants or partners, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and Indian/Native American Tribal Governments that are not federally recognized. It further notes eligibility for certain non-U.S. entities (foreign organizations), regional organizations, faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions. Overall, the eligibility language signals an openness to a wide ecosystem of research performers and collaborators, including organizations that can contribute specialized expertise or unique resources to basic cancer biology projects.
The funding instrument is a grant, and the activity category is listed under education and health, consistent with NIH biomedical research funding. The opportunity’s original closing date was August 6, 2018, and the record indicates it was created on July 5, 2018. No award ceiling or expected number of awards is specified in the provided source details, which is common in some administrative supplement announcements where available funds may depend on program priorities and appropriations, and where award size may vary based on the scope of the proposed supplement and the parent grant’s context.
In summary, this FOA is essentially an NCI tool for adding targeted funding to active NCI-supported projects to spark or deepen collaborative, multidisciplinary basic cancer research. Applicants are expected to propose a well-justified partnership that clearly builds on and extends the parent grant’s scientific foundation, while keeping the work outside the realm of clinical trials.Apply for PA 18 852
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396.
- This funding opportunity was created on 2018-07-05.
- Applicants must submit their applications by 2018-08-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this NIH/NCI grant opportunity?
The opportunity is titled "Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed)".
Which agency is offering this funding opportunity?
The funding opportunity is announced by the National Institutes of Health (NIH), through the National Cancer Institute (NCI).
What is the funding opportunity number (FOA)?
The funding opportunity number is PA 18 852.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 93.396.
What type of funding mechanism is this?
This is an administrative supplement mechanism, meaning it provides additional funds to expand or enhance work already supported by an active NCI parent award rather than supporting a brand-new standalone project.
Does this opportunity fund entirely new research projects?
No. Based on the description provided, the supplement is intended to build on an active NCI parent award by extending or strengthening the currently funded work through new collaborative activities.
What is the overall scientific focus of the supplement?
The focus is basic cancer biology, with an emphasis on addressing challenging research questions by promoting multidisciplinary collaboration and bringing together complementary expertise.
What is the main purpose of the administrative supplement?
The main purpose is to promote collaborative activities that leverage the infrastructure, aims, and momentum of an existing NCI-funded parent grant, while meaningfully extending that work through partnership.
Is collaboration required?
Yes. A central requirement is that the proposed supplement must be built around a genuine collaboration involving at least two researchers.
Who must be included in the collaboration?
One collaborator must be the principal investigator (PI) of the existing parent NCI grant.
How many researchers need to be involved?
At minimum, the supplement must involve at least two researchers as part of a genuine collaboration, and one must be the PI of the parent award.
What kinds of collaborations does NCI appear to be encouraging?
NCI is encouraging collaborations that cut across disciplines and combine complementary skill sets, approaches, or technologies that may not exist within a single lab or research group.
Are clinical trials allowed under this supplement?
No. The opportunity is explicitly labeled "Clinical Trial Not Allowed", which indicates that supported activities should remain outside interventional human studies and stay within basic or preclinical/fundamental cancer biology research boundaries.
What is the funding instrument for this opportunity?
The funding instrument is a grant.
What is the activity category listed for this opportunity?
The activity category is listed under education and health, consistent with NIH biomedical research funding.
Who is eligible to apply (in general terms)?
Eligibility is broad and includes many types of applicants commonly allowed under NIH grants, including domestic governments, higher education institutions, nonprofit organizations, for-profit organizations (other than small businesses), and small businesses. The description also notes eligibility or inclusion of certain non-U.S. entities and other organization types.
Are state, county, or local governments eligible applicants?
Yes. The opportunity includes state, county, and local governments among eligible applicant types.
Are institutions of higher education eligible?
Yes. Both public and state-controlled institutions of higher education and private institutions of higher education are listed as eligible.
Are nonprofit organizations eligible?
Yes. The announcement allows nonprofit organizations with 501(c)(3) status and nonprofit organizations without 501(c)(3) status.
Are for-profit organizations eligible?
Yes. For-profit organizations (other than small businesses) are listed as eligible, and small businesses are also included as eligible applicants.
Are independent school districts eligible?
Yes. Independent school districts are included in the eligibility list.
Are special district governments eligible?
Yes. Special district governments are included among eligible applicants.
Are public housing authorities or Indian housing authorities eligible?
Yes. Public housing authorities or Indian housing authorities are listed among eligible applicants.
Does the FOA highlight specific institution types as eligible or welcomed?
Yes. It explicitly highlights a range of institutions and organizations, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Are Indian/Native American Tribal Governments that are not federally recognized included?
Yes. The eligibility language includes Indian/Native American Tribal Governments that are not federally recognized.
Are foreign organizations or non-U.S. entities eligible?
Yes. The description notes eligibility for certain non-U.S. entities (foreign organizations), as well as regional organizations.
Are faith-based or community-based organizations eligible?
Yes. The eligibility language indicates that faith-based or community-based organizations are eligible.
Are federal agencies eligible?
Yes. The description includes eligible federal agencies.
Are U.S. territories or possessions included?
Yes. The eligibility language includes U.S. territories or possessions.
What is the key constraint on what the supplement can support?
The key constraints described are that the work must (1) be tied to an active NCI parent award, (2) be built around a true collaboration with at least two researchers including the parent PI, and (3) remain within basic cancer research with no clinical trials.
Does the provided information specify an award ceiling?
No. The provided details state that no award ceiling is specified.
Does the provided information specify the expected number of awards?
No. The provided details state that no expected number of awards is specified.
When was the opportunity record created?
The record indicates it was created on July 5, 2018.
What was the original closing date listed for this opportunity?
The original closing date was August 6, 2018.
Why might award size and number of awards not be listed for an administrative supplement?
Based on the provided description, this can be common for administrative supplement announcements because available funds may depend on program priorities and appropriations, and award size may vary depending on the scope of the supplement and the context of the parent grant.
What is the core idea behind this FOA in plain terms?
It is an NCI tool for adding targeted funding to an already active NCI-supported project to spark or deepen multidisciplinary collaboration in basic cancer research, while clearly excluding clinical trials.
Browse more opportunities from the same category: Education, Health
Next opportunity: Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Previous opportunity: Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 852
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 852) also looked into and applied for these:
| Funding Opportunity |
|---|
| Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional) Apply for PA 18 863 Funding Number: PA 18 863 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional) Apply for PA 18 861 Funding Number: PA 18 861 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional) Apply for PA 18 862 Funding Number: PA 18 862 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Apply for PAR 18 869 Funding Number: PAR 18 869 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) Apply for PA 18 876 Funding Number: PA 18 876 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) Apply for PAR 18 877 Funding Number: PAR 18 877 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Apply for PAR 18 880 Funding Number: PAR 18 880 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Not Allowed) Apply for PAR 18 881 Funding Number: PAR 18 881 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Required) Apply for PAR 18 882 Funding Number: PAR 18 882 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 18 887 Funding Number: PAR 18 887 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 18 888 Funding Number: PAR 18 888 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Apply for PAR 18 892 Funding Number: PAR 18 892 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Apply for PAR 18 893 Funding Number: PAR 18 893 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) Apply for PAR 18 896 Funding Number: PAR 18 896 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed) Apply for RFA CA 18 012 Funding Number: RFA CA 18 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) Apply for PA 18 902 Funding Number: PA 18 902 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed) Apply for RFA LM 19 001 Funding Number: RFA LM 19 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional) Apply for RFA CA 18 028 Funding Number: RFA CA 18 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional) Apply for RFA CA 18 027 Funding Number: RFA CA 18 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required) Apply for RFA CA 18 018 Funding Number: RFA CA 18 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 852", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.